Clinical Trial Update: Effects of TT301 on Cytokine Levels Post Endotoxin Challenge [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating TT301's effect on cytokine levels after endotoxin challenge in traumatic brain injury; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• TT301

Snippet

Sponsor: OPKO Health, Inc. | Conditions: Traumatic Brain Injury | Phase 1 | Status: COMPLETED